MGMT Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MGMT Antibodies for research focused on O6-methylguanine-DNA methyltransferase (MGMT) in cellular processes. MGMT Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MGMT is a crucial DNA repair protein that protects cells from the toxic effects of alkylating agents by removing alkyl groups from the O6 position of guanine. The function of MGMT is essential in maintaining genomic stability and preventing mutations that can lead to cancer. Dysregulation of MGMT expression has been implicated in various malignancies, making it an important target for therapeutic interventions and a key focus in cancer research. MGMT plays a significant role in DNA repair mechanisms and cellular defense against mutagenic agents. Research has shown that MGMT expression levels can influence treatment outcomes in various cancer types. Understanding MGMT activity and regulation is crucial for developing targeted cancer therapies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cancer research and therapeutic development through precise detection and analysis of MGMT.